Application of a Seamless and Restriction Endonuclease-free Cloning Method to Produce Recombinant Full-length N-terminal His-tagged Streptolysin O in E.coli

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 54

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JIML-4-3_004

تاریخ نمایه سازی: 14 مرداد 1402

Abstract:

Background and Aims: DNA cloning, sub-cloning and site directed mutagenesis are the most common strategies in nearly all projects of recombinant protein production. The classical method of restriction site cloning is unsatisfactory due to the need for supply of restriction enzymes and the inefficiency of the digestion reaction. Many new methods, including recombinatorial cloning and ligation independent cloning need additional enzymes and kits. In this project we insert a full-length streptolysin O gene into an expression plasmid without using any uncommon commercial enzymes. Materials and Methods: Steptolysin O gene was amplified by polymerase chain reaction (PCR) and introduced into the pPSG-IBA۳۵ vector using a quick-change PCR. At the same time the gene was double digested and sub-cloned into pET۲۸a (+). Both constructs were introduced into BL۲۱ DE۳ cell. Proteins were purified by Ni-NTA column and hemolytic activity was evaluated by spectrophotometry using human red blood cells. Results: Steptolysin O was subcloned into the pET۲۸a (+) and pPSG-IBA۳۵ vectors and expressed in E. coli. Protein was purified with over ۹۰% purity. The IC۵۰ of C and N terminus his-tagged protein were ۰.۲۲ and ۰.۲۹ µg/ml, respectively in hemolysis assay. Conclusions: This study showed for the first time that full-length streptolysin O can be expressed in E. coli cytoplasm without any toxicity for the bacteria itself. The only additional amino acids expressed on the protein were his-tag. To study the role of this toxin it would be better to express the protein with the same strategy to have minimal extra amino acids on the protein.

Authors

محمد حسن خیراندیش

Department of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

حسین زارعی جلیانی

Department of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. ۲Department of Advanced Medical Sciences and Technologies, Faculty of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

بهناز رحمانی

Department of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • . Iacovache I, van der Goot FG, Pernot L. Pore ...
  • . Thorsen T, Klausen H, Lie RT, Holmsen H. Pore-forming ...
  • . Gonzalez MR, Bischofberger M, Pernot L, van der Goot ...
  • . Lemichez E, Barbieri JT. General aspects and recent advances ...
  • . Hotze EM, Tweten RK. Membrane assembly of the cholesterol-dependent ...
  • . Heuck AP, Moe PC, Johnson BB. The cholesterol-dependent cytolysin ...
  • . Sierig G, Cywes C, Wessels MR, Ashbaugh CD. Cytotoxic ...
  • . Bernheimer AW, Avigad LS. Streptolysin o: activation by thiols. ...
  • . Pinkney M, Beachey E, Kehoe M. The thiol-activated toxin ...
  • . Ben-Chetrit E, Moses AE, Agmon-Levin N, Block C, Ben-Chetrit ...
  • . Uckay I, Ferry T, Stern R, Ambrosioni J, Gamulin ...
  • . Tanigawa T, Suzuki J, Ueta T, Katsumoto T, Tanaka ...
  • . Yang WS, Park SO, Yoon AR, Yoo JY, Kim ...
  • . Walev I, Bhakdi SC, Hofmann F, Djonder N, Valeva ...
  • . Spiller DG, Giles RV, Grzybowski J, Tidd DM, Clark ...
  • . Barry EL, Gesek FA, Friedman PA. Introduction of antisense ...
  • . Spiller DG, Tidd DM. Nuclear delivery of antisense oligodeoxynucleotides ...
  • . Ogino S, Kubo S, Umemoto R, Huang S, Nishida ...
  • . Brito JL, Davies FE, Gonzalez D, Morgan GJ. Streptolysin-O ...
  • . Kimoto H, Fujii Y, Hirano S, Yokota Y, Taketo ...
  • . Velazquez B, Massaldi H, Battistoni J, Chabalgoity JA. Construction ...
  • . Yamamoto I, Kimoto H, Taketo Y, Taketo A. Mutational ...
  • . Michos A, Gryllos I, Hakansson A, Srivastava A, Kokkotou ...
  • . Weller U, Muller L, Messner M, Palmer M, Valeva ...
  • . Bellomio A, Morante K, Barlic A, Gutierrez-Aguirre I, Viguera ...
  • . Hsieh PC, Vaisvila R. Protein engineering: single or multiple ...
  • . Li C, Wen A, Shen B, Lu J, Huang ...
  • . Rabhi I, Guedel N, Chouk I, Zerria K, Barbouche ...
  • . Unger T, Jacobovitch Y, Dantes A, Bernheim R, Peleg ...
  • . Horton RM. In vitro recombination and mutagenesis of DNA. ...
  • . Horton RM, Cai Z, Ho SM, Pease LR. Gene ...
  • . Pogulis RJ, Vallejo AN, Pease LR. In vitro recombination ...
  • . Vallejo AN, Pogulis RJ, Pease LR. PCR Mutagenesis by ...
  • . Barik S, Galinski MS. "Megaprimer" method of PCR: increased ...
  • . Sarkar G, Sommer SS. The "megaprimer" method of site-directed ...
  • . Tseng WC, Lin JW, Wei TY, Fang TY. A ...
  • نمایش کامل مراجع